Gamma-Synuclein Levels Are Elevated in Peritoneal Fluid of Patients with Endometriosis
- 23 March 2020
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e922137
- https://doi.org/10.12659/msm.922137
Abstract
Background: The role of gamma-synuclein (SNCG) has been widely examined in malignant conditions due to its possible role in disease progression, but very little information is available on its theoretical function on endometriosis formation. Material/Methods: Between January 2016 and December 2016, we collected peritoneal fluid and plasma samples from 45 consecutive female patients, of which 15 were without endometriosis, 15 had minimal to mild endometriosis, and 15 had moderate to severe endometriosis. The statistical power was 0.98. We evaluated SNCG levels in the peritoneal fluid and plasma of patients diagnosed with endometriosis, and we compared them with the levels obtained from disease-free control subjects by using enzyme-linked immunosorbent assay. Results: SNCG levels were statistically significantly (1.2-fold) higher in the peritoneal fluid of patients with endometriosis compared to controls (p=0.04). We did not find a significant difference between SNCG levels in the plasma of our endometriosis patients and the control group (p=0.086). However, despite previous data showing very limited expression of SNCG in healthy tissues, we found SNCG in the peritoneal fluid of all of the patients in our healthy control group. Conclusions: Levels of SNCG were statistically significantly higher in the peritoneal fluid of patients with endometriosis compared to disease-free controls, which may indicate its possible role the formation and progression of the disease. Moreover, its biological function should be further investigated due to the conflicting results concerning its expression in healthy tissues.This publication has 26 references indexed in Scilit:
- Consensus on current management of endometriosisHuman Reproduction, 2013
- Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosisNeurobiology of Disease, 2012
- New trends for the medical treatment of endometriosisExpert Opinion on Investigational Drugs, 2012
- An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancerBMJ Open, 2012
- Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinomaGynecologic Oncology, 2012
- Potential Markers for Detection and Monitoring of Ovarian CancerJournal of Oncology, 2011
- Endometriosis and infertilityJournal of Assisted Reproduction and Genetics, 2010
- Synuclein-γ (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinomaGynecologic Oncology, 2009
- Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosisFertility and Sterility, 2008
- γ Synuclein, a Novel Heat-Shock Protein-Associated Chaperone, Stimulates Ligand-Dependent Estrogen Receptor α Signaling and Mammary TumorigenesisCancer Research, 2004